Hevia Oscar
Aesthet Surg J Open Forum. 2022 Apr 22;4:ojac030. doi: 10.1093/asjof/ojac030. eCollection 2022.
Polymethylmethacrylate (PMMA)-collagen gel is approved for the correction of nasolabial folds and severe atrophic, distensible facial acne scars on the cheek. However, fillers are often used off-label in clinical practice, necessitating additional study of safety and efficacy.
To determine the safety and efficacy of PMMA-collagen gel for the correction of lower face aging, specifically the pre-jowl sulcus.
In this prospective, single-center, 1-year study (N = 20) and additional 1-year extension (N = 10), 20 patients with a pretreatment score of 2, 3, or 4 on the 5-point Merz Aesthetic Scale for jawline at rest were eligible for treatment with PMMA-collagen gel. Efficacy was measured by blinded review using the jawline scale, Subject and Physician Global Aesthetic Improvement Scale (GAIS) and Subject Satisfaction scores, collected at weeks 4, 12, 26, 52, and 104.
Improvement in jawline score was significant at all posttreatment time points up to 104 weeks ( < 0.01). The percentage of patients with subject-reported GAIS ratings of "improved" or "much improved" was 79% at 12 weeks and ratings were maintained at 76% at 52 weeks and increased to 90% at week 104. At 52 and 104 weeks, 82% and 100% of patients, respectively, were at least "somewhat satisfied." All adverse events were minor.
PMMA-collagen gel is well tolerated and effective for durable correction of the pre-jowl sulcus and jawline.
聚甲基丙烯酸甲酯(PMMA)-胶原蛋白凝胶已被批准用于矫正鼻唇沟以及脸颊上严重萎缩、可扩张的面部痤疮瘢痕。然而,在临床实践中填充剂常常被超适应证使用,因此有必要对其安全性和有效性进行更多研究。
确定PMMA-胶原蛋白凝胶用于矫正下面部老化,特别是下颌前沟的安全性和有效性。
在这项前瞻性、单中心、为期1年的研究(N = 20)以及额外的1年延长期研究(N = 10)中,20例静息时下颌轮廓在5分Merz美学量表上预处理评分为2、3或4分的患者有资格接受PMMA-胶原蛋白凝胶治疗。通过使用下颌轮廓量表、受试者和医生整体美学改善量表(GAIS)以及受试者满意度评分进行盲法评估来衡量疗效,这些评分在第4、12、26、52和104周收集。
直至104周的所有治疗后时间点,下颌轮廓评分均有显著改善(P < 0.01)。受试者报告GAIS评分为“改善”或“明显改善”的患者百分比在12周时为79%,在52周时保持在76%,并在第104周增至90%。在52周和104周时,分别有82%和100%的患者至少“有些满意”。所有不良事件均较轻微。
PMMA-胶原蛋白凝胶耐受性良好,对于持久矫正下颌前沟和下颌轮廓有效。